Similar Items: Bacteremic versus Non-Bacteremic Urinary Tract Infections: Predictors of Poor Clinical Outcome
- Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
- Correction to: Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
- Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection
- Carbapenem resistance in community-acquired urinary tract infections caused by Klebsiella pneumoniae and Escherichia coli in Morocco: a multicentre study (January 2022–December 2023)‘Carbapenem resistance in community UTIs in Morocco’
- Patients referred to but not taken on to an outpatient parenteral antimicrobial therapy (OPAT) service: the impact of infection specialist advice on the assessment and clinical outcomes
- A study of urinary tract infections in renal transplant patients